Drug
GSK 835726 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
- GSK835726
- 1
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses GSK 835726 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedPhase 1GlaxoSmithKlineNCT00605852Written as GSK835726
- 723/726 Proof of Concept Study in Allergen Challenge Chamber in HannoverCompletedPhase 2GlaxoSmithKlineNCT00972504Written as GSK835726 10mg
- Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With PlaceboCompletedPhase 2GlaxoSmithKlineNCT00851344Written as GSK835726 (10mg)
Codes
What other systems call GSK 835726 · ClinicalTrials.gg INT005845
- MeSH (NLM) C558852GSK 835726One source ClinicalTrials.gov
- Wikidata Q27295117gsk-835726One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C558852 | GSK 835726 | One source ClinicalTrials.gov |
| Wikidata | Q27295117 | gsk-835726 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.